Back
Science

Patient Sustained 48 Hours Without Lungs Using Artificial System Prior to Double Lung Transplant

Generated on: Last updated: 2 sources
View source

Northwestern Surgeons Sustain Patient Without Lungs for 48 Hours Using Novel Artificial System, Enable Successful Transplant

Surgeons at Northwestern University successfully sustained a 33-year-old male patient for 48 hours without lungs using a novel artificial lung system, subsequently performing a double lung transplant. The patient, who suffered from severe acute respiratory distress syndrome (ARDS), recovered and maintained good lung function over two years post-surgery. This remarkable case report, published in the Cell Press journal Med, details the use of the extracorporeal Total Artificial Lung (TAL) system to facilitate transplantation in a challenging clinical scenario.

Patient's Critical Condition

The 33-year-old patient developed acute respiratory distress syndrome (ARDS) stemming from influenza B and bacterial pneumonia. His condition rapidly progressed to include necrotizing pneumonia, a carbapenem-resistant infection, and bilateral empyemas. This dire situation led to the failure of his lungs, heart, and kidneys, along with recurrent cardiac arrest due to refractory septic shock.

Prior to the novel intervention, the patient received maximal antimicrobial therapy and venoarterial extracorporeal membrane oxygenation (ECMO). Despite these intensive treatments, his condition remained unstable, preventing immediate lung transplantation. The infected lungs were critically contributing to a systemic infection, and their injury was considered irreversible.

Radical Intervention: Bilateral Pneumonectomy and TAL System

To address the rapidly deteriorating condition and allow for potential transplantation, a bilateral pneumonectomy (the surgical removal of both lungs) was performed as salvage therapy.

Following the pneumonectomy, extracorporeal support transitioned to the novel Total Artificial Lung (TAL) system. This system was designed to provide gas exchange and hemodynamic buffering functions.

Key features of the TAL system included an adaptive shunt and dual left atrial return pathways, which helped maintain physiological circulation and cardiac stability by preventing acute right ventricular distension. The system effectively oxygenated the blood, removed carbon dioxide, and maintained stable blood flow.

Stabilization and Successful Transplantation

Within hours of TAL initiation, the patient's hemodynamic status improved. Vasopressors were discontinued after 12 hours, and serum lactate levels normalized within 24 hours. Oxygen saturations improved, and organ function remained stable for the 48-hour period. Remarkably, there was no evidence of intracardiac thrombus formation despite the absence of systemic anticoagulation. The infection also began to subside.

After 48 hours of support on the TAL system, donor lungs became available, and a double lung transplant was successfully performed.

Remarkable Recovery and Long-Term Health

The patient was extubated seven days post-transplant and discharged eight weeks later. Primary graft dysfunction resolved by day three, and surveillance biopsies showed no signs of rejection.

At 24 months post-surgery, the patient maintained functional independence with excellent lung function metrics, including 75% forced expiratory volume in one second (FEV1) and 92% diffusing capacity. Cardiac function was also preserved.

Molecular Insights from Explanted Lungs

Researchers conducted a molecular analysis of the patient's removed lungs. This analysis revealed extensive necrosis, fibrosis, and immune infiltration, consistent with end-stage ARDS.

Key findings included:

  • T-cell expansion and plasma cell differentiation.
  • B-cell depletion.
  • Replacement of alveolar macrophages by profibrotic monocyte-derived macrophages.
  • Epithelial analysis showed failed regeneration with aberrant basaloid cells and depleted alveolar type 2 cells.
  • Spatial transcriptomics demonstrated complete architectural effacement with profibrotic remodeling, confirming irreversible end-stage injury.

These findings provided crucial molecular evidence supporting the necessity of double lung transplantation for survival in some ARDS patients with similar severe lung damage.

Implications and Future Directions

This case report highlights the successful application of the novel TAL system in managing refractory septic ARDS, enabling hemodynamic stabilization and subsequent transplantation.

Researchers noted that this advanced approach is currently limited to specialized centers, with a stated goal for the concept to evolve into more standardized devices to support patients awaiting new lungs.

Further prospective validation is required to define patient selection criteria, optimal timing for intervention, and to identify molecular signatures that can differentiate irreversible from recoverable ARDS earlier in the disease course.